XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Shares Of Common Stock
Accumulated Other Comprehensive Income (Loss)
Dividends declared per share (usd per share) $ 0.60            
Beginning Period Balance at Dec. 31, 2018 $ 4,825,588 $ 1,251 $ 3,722,723 $ 1,182,674 $ (74,985)   $ (6,075)
Shares outstanding, beginning balance (shares) at Dec. 31, 2018   123,189,833          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings 112,604     112,604      
Other comprehensive income - net unrealized gain on securities available-for-sale, net of tax 43,333           43,333
Restricted stock awarded and earned compensation, net of shares forfeited (shares)   195,536          
Restricted stock awarded and earned stock compensation, net of shares forfeited 5,808 $ 2 5,806        
Restricted stock surrendered (shares)   (113,544)       (3,070,676)  
Restricted stock surrendered (4,522)       (4,522)    
Common stock repurchased under Stock Repurchase Program (31)            
Common stock repurchased under Stock Repurchase Program (119,587)   (119,556)        
Cash dividends paid (73,180)   (73,180)        
Ending Period Balance at Mar. 31, 2019 4,790,982 $ 1,222 3,535,793 1,296,216 (79,507)   37,258
Shares outstanding, ending balance (shares) at Mar. 31, 2019   120,201,149          
Stockholders' Equity Disclosure [Rollforward]              
New Accounting Pronouncement, Effect of Change on Net Income 938 [1]     938 [1]     0
Beginning Period Balance at Dec. 31, 2018 4,825,588 $ 1,251 3,722,723 1,182,674 (74,985)   (6,075)
Shares outstanding, beginning balance (shares) at Dec. 31, 2018   123,189,833          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings 240,729            
Ending Period Balance at Jun. 30, 2019 $ 4,852,010 $ 1,219 3,435,679 1,424,341 (82,295)   73,066
Shares outstanding, ending balance (shares) at Jun. 30, 2019   119,829,104          
Dividends declared per share (usd per share) $ 0.60            
Beginning Period Balance at Mar. 31, 2019 $ 4,790,982 $ 1,222 3,535,793 1,296,216 (79,507)   37,258
Shares outstanding, beginning balance (shares) at Mar. 31, 2019   120,201,149          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings 128,125     128,125      
Other comprehensive income - net unrealized gain on securities available-for-sale, net of tax 35,808           35,808
Restricted stock awarded and earned compensation, net of shares forfeited (shares)   619,653          
Restricted stock awarded and earned stock compensation, net of shares forfeited 6,721 $ 6 6,715        
Restricted stock surrendered (shares)   (74,429)       (917,269)  
Restricted stock surrendered (2,788)       (2,788)    
Common stock repurchased under Stock Repurchase Program (9)            
Common stock repurchased under Stock Repurchase Program (34,929)   (34,920)        
Cash dividends paid (71,909)   (71,909)        
Ending Period Balance at Jun. 30, 2019 $ 4,852,010 $ 1,219 3,435,679 1,424,341 (82,295)   73,066
Shares outstanding, ending balance (shares) at Jun. 30, 2019   119,829,104          
Dividends declared per share (usd per share) $ 0.60            
Beginning Period Balance at Dec. 31, 2019 $ 4,954,697 $ 1,219 3,306,006 1,652,248 (83,434)   78,658
Shares outstanding, beginning balance (shares) at Dec. 31, 2019   119,781,605          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings (1,433,111)     (1,433,111)      
Other comprehensive income - net unrealized gain on securities available-for-sale, net of tax 12,258           12,258
Restricted stock awarded and earned compensation, net of shares forfeited (shares)   194,916          
Restricted stock awarded and earned stock compensation, net of shares forfeited 6,494 $ 2 6,492        
Restricted stock surrendered (shares)   (106,021)       (1,953,711)  
Restricted stock surrendered (3,460)       (3,460)    
Common stock repurchased under Stock Repurchase Program (20)            
Common stock repurchased under Stock Repurchase Program (70,000)   (69,980)        
Cash dividends paid (71,206)   (71,206)        
Ending Period Balance at Mar. 31, 2020 3,390,389 $ 1,201 3,171,312 213,854 (86,894)   90,916
Shares outstanding, ending balance (shares) at Mar. 31, 2020   117,916,789          
Stockholders' Equity Disclosure [Rollforward]              
New Accounting Pronouncement, Effect of Change on Net Income [2] (5,283)     (5,283)      
Beginning Period Balance at Dec. 31, 2019 4,954,697 $ 1,219 3,306,006 1,652,248 (83,434)   78,658
Shares outstanding, beginning balance (shares) at Dec. 31, 2019   119,781,605          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings (1,399,907)            
Ending Period Balance at Jun. 30, 2020 $ 3,452,898 $ 1,207 3,148,090 247,058 (88,495)   145,038
Shares outstanding, ending balance (shares) at Jun. 30, 2020   118,374,603          
Dividends declared per share (usd per share) $ 0.25            
Beginning Period Balance at Mar. 31, 2020 $ 3,390,389 $ 1,201 3,171,312 213,854 (86,894)   90,916
Shares outstanding, beginning balance (shares) at Mar. 31, 2020   117,916,789          
Stockholders' Equity Disclosure [Rollforward]              
Net earnings 33,204     33,204      
Other comprehensive income - net unrealized gain on securities available-for-sale, net of tax 54,122           54,122
Restricted stock awarded and earned compensation, net of shares forfeited (shares)   550,738          
Restricted stock awarded and earned stock compensation, net of shares forfeited 6,289 $ 6 6,283        
Restricted stock surrendered (shares)   (92,924)          
Restricted stock surrendered (1,601)       (1,601)    
Cash dividends paid (29,505)   (29,505)        
Ending Period Balance at Jun. 30, 2020 $ 3,452,898 $ 1,207 $ 3,148,090 $ 247,058 $ (88,495)   $ 145,038
Shares outstanding, ending balance (shares) at Jun. 30, 2020   118,374,603          
[1] Impact due to adoption on January 1, 2019 of ASU 2016-02, "Leases (Topic 842)," and the related amendments.
[2] Impact due to adoption on January 1, 2020 of ASU 2016-13, "Financial Instruments - Credit Losses (ASC 326): Measurement of Credit Losses on Financial Instruments," and the related amendments, commonly referred to as CECL.